Woods qualified in medicine from Cambridge in 1972, followed by higher clinical training in Birmingham and epidemiological training at Harvard School of Public Health.
In 1984 he was appointed senior lecturer in Clinical Pharmacology at Leicester University, where he now holds a personal chair in therapeutics. His clinical and research interests have been in coronary heart disease.
Prior to this, Woods was regional director of r&d, NHS Executive Trent, from 1995–1999 before becoming director of the NHS Health Technology Assessment programme.
Woods took up the post of chief executive at the MHRA in January 2004.
MHRA chief executive awarded knighthood
Professor Kent Woods is recognised for his services to healthcare
You may also like
Regulatory
MHRA joins international partnerships to set global standards for medicines and medical devices regulation
The UK is set to play a greater international role in making sure medicines and medical devices are regulated safely and efficiently worldwide, the Medicines and Healthcare products Regulatory Agency (MHRA) has announced after being accepted as a full member of three international work-sharing partnerships
